Neuphoria Therapeutics Inc. (NEUP)
NASDAQ: NEUP · Real-Time Price · USD
4.770
+0.050 (1.06%)
At close: May 19, 2026, 4:00 PM EDT
4.448
-0.322 (-6.76%)
After-hours: May 19, 2026, 7:50 PM EDT

Neuphoria Therapeutics Income Statement

Millions USD. Fiscal year is Jul - Jun.
Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Mar '26 Jun '25 Jun '24 Jun '23 Jun '22 Jun '21
-0.0115.65----
Gross Profit
-0.0115.65----
Selling, General & Admin
7.757.778.478.91--
Research & Development
7.729.019.4213.07-11.04-4.32
Other Operating Expenses
1.28-----
Total Operating Expenses
16.7516.7817.8921.98-11.04-4.32
Operating Income
-16.76-1.13-17.89-21.9811.044.32
Interest Income
0.580.170.220.320.010
Other Non-Operating Income (Expense)
-1.620.122.090.14--
Total Non-Operating Income (Expense)
-1.040.292.310.460.010
Pretax Income
-17.8-0.84-15.58-21.52-15.14-6.66
Provision for Income Taxes
-0.37-0.47-0.09-0.14-0.13-0.14
Net Income
-7.36-0.37-15.49-21.38-15.01-6.52
Net Income to Common
-7.36-0.37-15.49-21.38-15.01-6.52
Shares Outstanding (Basic)
421110
Shares Outstanding (Diluted)
421110
Shares Change (YoY)
161.21%95.01%22.38%8.53%73.52%-99.93%
EPS (Basic)
-9.88-0.23-18.62-43.20-29.79-16.19
EPS (Diluted)
-11.06-0.23-18.62-43.20-29.79-16.19
Shares Outstanding
5.381.981.10.680.630.47
Free Cash Flow
-17.150.08-14.68-14.22-15.01-5.65
Free Cash Flow Per Share
-4.870.05-17.64-20.91-23.95-15.66
Gross Margin
100.00%100.00%----
Operating Margin
126330.00%-7.21%----
Profit Margin
131387.00%-2.36%----
FCF Margin
129283.00%0.49%----
EBITDA
-16.1-0.47-17.23-21.2111.85.6
EBITDA Margin
121333.00%-2.98%----
EBIT
-16.76-1.13-17.89-21.9811.044.32
EBIT Margin
126330.00%-7.21%----
Effective Tax Rate
2.08%55.89%0.56%0.65%0.87%2.11%
Updated May 15, 2026. Data Source: Fiscal.ai. Standard template. Financial Sources.
SEC Filings: 10-K · 10-Q